Cavallari LH - Search Results

1

Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.

Cavallari LH, Shin J, Perera MA. Cavallari LH, et al. Pharmacotherapy. 2011 Dec;31(12):1192-207. doi: 10.1592/phco.31.12.1192. Pharmacotherapy. 2011. PMID: 22122181 Free PMC article. Review.

2

Racial differences in patients' potassium concentrations during spironolactone therapy for heart failure.

Cavallari LH, Fashingbauer LA, Beitelshees AL, Groo VL, Southworth MR, Viana MA, Williams RE, Dunlap SH. Cavallari LH, et al. Pharmacotherapy. 2004 Jun;24(6):750-6. doi: 10.1592/phco.24.8.750.36076. Pharmacotherapy. 2004. PMID: 15222665

3

Sex difference in the antiplatelet effect of aspirin in patients with stroke.

Cavallari LH, Helgason CM, Brace LD, Viana MA, Nutescu EA. Cavallari LH, et al. Ann Pharmacother. 2006 May;40(5):812-7. doi: 10.1345/aph.1G569. Epub 2006 Apr 11. Ann Pharmacother. 2006. PMID: 16608908

4

Association of beta-blocker dose with serum procollagen concentrations and cardiac response to spironolactone in patients with heart failure.

Cavallari LH, Momary KM, Groo VL, Viana MA, Camp JR, Stamos TD. Cavallari LH, et al. Pharmacotherapy. 2007 Jun;27(6):801-12. doi: 10.1592/phco.27.6.801. Pharmacotherapy. 2007. PMID: 17542763 Clinical Trial.

5

Warfarin pharmacogenomics.

Cavallari LH, Limdi NA. Cavallari LH, et al. Curr Opin Mol Ther. 2009 Jun;11(3):243-51. Curr Opin Mol Ther. 2009. PMID: 19479657 Review.

6

Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.

Nochowitz B, Shapiro NL, Nutescu EA, Cavallari LH. Nochowitz B, et al. Among authors: cavallari lh. Ann Pharmacother. 2009 Jul;43(7):1165-72. doi: 10.1345/aph.1L707. Epub 2009 Jun 23. Ann Pharmacother. 2009. PMID: 19549747

7

Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure.

Cavallari LH, Groo VL, Viana MA, Dai Y, Patel SR, Stamos TD. Cavallari LH, et al. Pharmacotherapy. 2010 Jan;30(1):1-9. doi: 10.1592/phco.30.1.1. Pharmacotherapy. 2010. PMID: 20030467

8

Genetic and clinical predictors of warfarin dose requirements in African Americans.

Cavallari LH, Langaee TY, Momary KM, Shapiro NL, Nutescu EA, Coty WA, Viana MA, Patel SR, Johnson JA. Cavallari LH, et al. Clin Pharmacol Ther. 2010 Apr;87(4):459-64. doi: 10.1038/clpt.2009.223. Epub 2010 Jan 13. Clin Pharmacol Ther. 2010. PMID: 20072124

9

Pharmacogenomics of warfarin dose requirements in Hispanics.

Cavallari LH, Momary KM, Patel SR, Shapiro NL, Nutescu E, Viana MA. Cavallari LH, et al. Blood Cells Mol Dis. 2011 Feb 15;46(2):147-50. doi: 10.1016/j.bcmd.2010.11.005. Epub 2010 Dec 24. Blood Cells Mol Dis. 2011. PMID: 21185752

10

The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.

Perera MA, Gamazon E, Cavallari LH, Patel SR, Poindexter S, Kittles RA, Nicolae D, Cox NJ. Perera MA, et al. Among authors: cavallari lh. Clin Pharmacol Ther. 2011 Mar;89(3):408-15. doi: 10.1038/clpt.2010.322. Epub 2011 Jan 26. Clin Pharmacol Ther. 2011. PMID: 21270790 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters